Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
AV

Andreas Verras — 6 Patents

Merck: 4 patents #2,516 of 9,382Top 30%
SASyngenta Crop Protection Ag: 1 patents #315 of 703Top 45%
New York, NY: #3,367 of 20,192 inventorsTop 20%
New York: #23,374 of 115,490 inventorsTop 25%
Overall (All Time): #779,687 of 4,157,543Top 20%
6 Patents All Time
Andreas Verras has been granted 6 US patents while listed as an inventor at Merck. The first was granted in 2013 and the most recent in June 2025. Andreas Verras ranks #779,687 of 4,157,543 US inventors in our database (top 18.8%). Patent records list Andreas Verras in New York, NY, US.

Patents per Year

Patents granted per year, 2013 to 2025Bar chart with a peak of 2 patents in 2019.peak 22013: 1 patents20132019: 2 patents20192021: 1 patents20212025: 2 patents2025

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12331046 CTPS1 inhibitors and uses thereof Kevin D. Kreutter, Lewis Whitehead, Angela V. West, Steven K. Albanese, Shaughnessy Robinson +3 more 2025-06-17
12264134 Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Dane Clausen, Ping Chen, Xavier Fradera, Liangqin Guo, Yongxin Han +10 more 2025-04-01
11104690 Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 Dong-Ming Shen, Thomas H. Graham, Wensheng Liu, Clare Tudge, Jinlong Jiang 2021-08-31 $154,425,000
10414774 Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease Jared N. Cumming, Kevin D. Dykstra, Alan Hruza, Derun Li, Hong Liu +4 more 2019-09-17 $91,414,000
10414775 Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease John P. Caldwell, Mary Ann Caplen, Jared N. Cumming, Kevin D. Dykstra, Alan Hruza +12 more 2019-09-17 $91,414,000
8377953 Isothiazole and pyrazole derivatives as fungicides Peter Ackermann, Carla Bobbio, Camilla Corsi, Ann Monica McGinley, Ruud Titulaeu +1 more 2013-02-19 $5,999,000